ESC 365 - Anti-arrhythmic drug treatment in children: evidence and experience

EHRA Premium Access

Anti-arrhythmic drug treatment in children: evidence and experience

Session: Management of arrhythmias in specific populations: paediatric, congenital and COVID-19

Topic: Congenital Heart Disease and Paediatric Cardiology

Speaker: Doctor N. Blom (Leiden, NL)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Nico Blom

Leiden University Medical Center, Leiden (Netherlands (The))

5 presentations

0 follower

4 more presentations in this session

Ablation of atrial arrhythmias in patients with congenital heart disease: does cardiac imaging predict the response to therapy?

Speaker: Doctor I. Roca Luque (Barcelona, ES)

Cardiac arrhythmia and COVID-19: what have we learnt from cardiac imaging techniques?

Speaker: Doctor M. Chubb (Palo Alto, US)

Incidence, risk factors and outcomes of atrial arrhythmias in adult patients with atrioventricular septal defects

Speaker: Doctor V. Waldmann (Paris, FR)

Management of arrhythmias in the paediatric population - discussion

Access the full session

Management of arrhythmias in specific populations: paediatric, congenital and COVID-19

Speakers: Doctor N. Blom, Doctor I. Roca Luque, Doctor M. Chubb, Doctor V. Waldmann

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources